ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A promising prognostic model for predicting survival of patients with HIV-related diffuse large B-cell lymphoma in the cART era

Chen, Juanjuan; Wu, Yihua; Kang, Zixin; Qin, Shanfang; Ruan, Guangjing; Zhao, Han; Tao, Xin; Xie, Zhiman*; Peng, Jie*广州医学院; 南方医科大学; 1
Cancer Medicine2023-6DOI: 10.1002/cam4.5957
7阅读
引用收藏
分享

摘要

BackgroundOptimization of risk stratification is important for facilitating prognoses and therapeutic decisions regarding diffuse large B-cell lymphoma (DLBCL). However, a simple and applicable prognostic tool is lacking for individuals with human immunodeficiency virus (HIV)-related DLBCL in the era of combined antiretroviral therapy (cART). MethodsThis retrospective multicenter observational study included 147 HIV-related DLBCL patients with histologically confirmed DLBCL from 2013 to 2020. The total group was divided into training (n = 78) and validation (n = 69) cohorts to derive the best prognostic score. Clinicopathological and characteristic biomarkers correlated with clinical outcomes were analyzed. ResultsAge, Ann Arbor stage, lactate dehydrogenase (LDH) ratio, bulky disease, and red blood cell distribution width (RDW) ratio retained robust independent correlations with overall survival (OS) in multivariate analysis. A new and practical prognostic model was generated and externally validated, classifying patients into three categories with significantly different survival rates. Moreover, the new index outperformed the International Prognostic Index (IPI) score (area under the curve values of 0.94 vs. 0.81 in the training cohort and 0.85 vs. 0.74 in the validation cohort, C-indices of 0.80 vs. 0.70 in the training cohort and 0.74 vs. 0.70 in the validation cohort, and integrated discrimination improvement values of 0.203 in the training cohort and 0.175 in the validation cohort) and was better at defining intermediate- and high-risk groups. The calibration curves performed satisfactorily for predicting 3-year OS in the training and validation cohorts. ConclusionsWe developed and validated a simple and feasible prognostic model for patients with HIV-related DLBCL that had more discriminative and predictive accuracy than the IPI score for risk stratification and individualized treatment in the cART era.

学科与关键词

关键词
diffuse large B-cell lymphomahuman immunodeficiency virusoverall survivalprognostic modelred blood cell distribution width ratio
相关
加载中…
  • A Novel Prognostic Score Including the CD4/CD8 for AIDS-Related Lymphoma
    Chen, Juanjuan*; Liu, Xuewu; Qin, Shanfang; Ruan, Guangjing; Lu, Aili; Zhang, Jinxin; Wu, Yihua; Xie, Zhiman*; Peng, Jie*Frontiers in Cellular and Infection Microbiology, 2022, 12: 919446.被引 1
  • A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study
    Cai, Jun; Tian, Xiaopeng; Ma, Shuyun; Zhong, Liye; Li, Wenyu; Wang, Liang; Guo, Linlang; Li, Zhihua; Wu, Yudan; Zhong, Guangzheng; Huang, Huiqiang; Xia, Zhongjun; Xia, Yi; Liu, Panpan; Su, Ning; Fang, Yu; Zhang, Yuchen; Cai, Qingqing*British Journal of Cancer, 2021, 125(3): 402-412.被引 4
  • Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma
    Chen, Qiushi; Ayer, Turgay; Nastoupil, Loretta J.; Koff, Jean L.; Staton, Ashley D.; Chhatwal, Jagpreet; Flowers, Christopher R.*LEUKEMIA & LYMPHOMA, 2016, 57(4): 842-851.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Medicine
发表日期
2023-06
卷期
第 12 卷, 第 11 期
页码
12470-12481
DOI
10.1002/cam4.5957
语言
ENGLISH
成果收录
SCIE

作者

  • C

    Chen, Juanjuan (第一作者)

    southern med univ

  • W

    Wu, Yihua

    southern med univ

查看全部 9 位作者收起作者
  • K

    Kang, Zixin

    southern med univ

  • Q

    Qin, Shanfang

    hosp guangxi zhuang autonomous reg

  • R

    Ruan, Guangjing

  • Z

    Zhao, Han

    southern med univ · guangzhou med univ

  • T

    Tao, Xin

    southern med univ

  • X

    Xie, Zhiman (通讯)

    1

  • P

    Peng, Jie (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417